Suwon, Gyeonggi-do, South Korea

Seok Hee Park

This inventor holds 1 USPTO granted patent. Top assignees: Medpacto Inc., Sungkyunkwan University, Yonsei University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seok Hee Park. Retrieved from https://idiyas.com/inventor/seok-hee-park-d1c2uxgd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seok Hee Park: Innovator in Cancer Diagnosis

Introduction

Seok Hee Park is a notable inventor based in Suwon, Gyeonggi-do, South Korea. He has made significant contributions to the field of cancer diagnosis through his innovative research and development.

Latest Patents

Seok Hee Park holds a patent titled "Methods for Diagnosing Cancer Using Anti-BAG2 Antibody." This patent represents a crucial advancement in the early detection and diagnosis of cancer, showcasing his commitment to improving healthcare outcomes.

Career Highlights

Throughout his career, Seok Hee Park has worked at prestigious institutions, including Sungkyunkwan University and Yonsei University. His experience in these academic environments has allowed him to collaborate with leading researchers and contribute to groundbreaking studies.

Collaborations

One of his notable collaborators is Kyung-Min Yang. Their partnership has likely fostered innovative ideas and research in the field of cancer diagnostics.

Conclusion

Seok Hee Park's work in cancer diagnosis exemplifies the impact of innovative thinking in healthcare. His contributions continue to inspire advancements in medical technology and research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…